2013 University of Nottingham offers PhD Scholarship in the field of Medicine for UK/EU Citizens in UK
About Scholarship: Dipeptidyl peptidase IV (DPP-IV) inhibitor is a novel glucose lowering agent increasingly used in the United Kingdom for the management of hyperglycaemia in patients with type 2 diabetes. Evidence from clinical trials suggest that this class of drugs may offer advantage over other oral glucose lowering therapy due to reduced risks of hypoglycaemia and neutrality effect on patients body weight. Guidelines from the National Institute of Clinical Excellence (NICE) have recommended for DPP-IV inhibitor to be considered as a second or third line drug for patients with type 2 diabetes, particularly where there are concerns about patient’s risk of weight gain or hypoglycaemia.
Study Subject: Vascular Medicine
Course Level: PhD
Scholarship By: University of Nottingham
Location: UK
Eligibility:
-Students should have, or will expect to attain at least a masters or a degree in either public health, epidemiology or health related sciences.
-In addition the candidate should have a good understanding of statistics, mathematics or computer science.
Scholarship Open for International Students: The Students of UK/EU can apply.Non UK/EU citizens are welcome to apply but the grant will not cover the additional international fees.
Duration: Three years
Cover: Total offer is of £13,590 per annum.
Apply: By mail
Deadline: 30 November 2012
Further Information: http://jobs.nottingham.ac.uk/vacancies.aspx?cat=345#j13301
